Effect of Age on the Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Lasmiditan (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 13 Sep 2017 Status changed from recruiting to completed.
- 22 Jun 2017 Status changed from not yet recruiting to recruiting.
- 13 Jun 2017 New trial record